Supernus Pharmaceuticals Inc's treatment for attention deficit hyperactivity disorder met the main goal of two trials, but shares fell about 16 percent on Thursday as the data failed to convince some investors that the drug was better than rivals.


40


Reuters

Latest News

FOX: Philadelphia Eagles' Lane Johnson donates $500G to Kilgore College for new athletic facility

FOX: Washington woman captures real-life ‘Bambi’ moment in cute video

FOX: Mueller must testify in Congress before any Trump impeachment process begins: Democratic Rep. Garamendi

CNN: 'American Taliban' to be released from prison

CBS: Giant asteroid with its own moon to pass by earth this weekend

ABC: Southwest Airlines mechanics approve contract, 20% raise

ABC: Suspect shot by police was free despite probation violations

ABC: NJ man arrested on charges of supporting Hamas, said he wanted to 'bomb Trump Tower'

ABC: A first: Washington Mystics top AP WNBA preseason poll

ABC: USOC leader: Reform possible with or without Congress

ABC: Ohio power company fulfills Louisiana wetlands agreement

NewYorkTimes: Trump’s Battles: Today’s State of Play

NewYorkTimes: San Francisco Police Call Freelancer Possible ‘Co-Conspirator’ in Report Leak

FOX: Cliff Maloney: Venezuela is a poster child for gun control gone wrong

FOX: Atletico Madrid star Diego Costa suffers ankle injury after slide tackle

FOX: 'NCIS' Season 16 finale shocks fans with surprise cameo

FOX: 'Game of Thrones' spinoff featuring Arya Stark isn't happening according to HBO boss

CBC: Winnipeg Cher fans disappointed after show suddenly cancelled

NewYorkTimes: Study Pinpoints Source of Banned Gas That Saps Ozone Layer: Eastern China

FOX: Conviction tossed for man held 33 years for New York murder

FOX: 'NCIS' Season 16 finale shocks fans with surprise cameo

FOX: 'Game of Thrones' spinoff featuring Arya Stark isn't happening according to HBO boss

FOX: Dem rebuked after calling child deaths ‘intentional’ in fiery exchange with DHS boss

19 Related Articles from 2018-12-06